← back to search

Stefania Salvagni

Azienda USL di Bologna · IT
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Epigenetics and DNA Methylation, Hepatocellular Carcinoma Treatment and Prognosis, Lung Cancer Treatments and Mutations, and Colorectal Cancer Treatments and Studies.
h-index
28
citations
3,341
works
86
NIH funding
—
primary concept
Medicine
email
stefania.salvagni@aosp.bo.it

Recent publications

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
Journal of Clinical Oncology 2024cited by 165position: middledoi
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
Journal of Thoracic Oncology 2019cited by 324position: middledoi
Role of dental prevention of bisphosphonates-related osteonecrosis of the jaws: 5 years longitudinal study in cancer patients
Europe PMC (PubMed Central) 2014cited by 0position: middle
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
The Lancet Oncology 2012cited by 550position: middledoi
Pain outcomes in patients with advanced breast cancer and bone metastases
Cancer 2012cited by 155position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Charles S. Cleeland · The University of Texas MD Anderson Cancer Center1 papers (2012–2012)Matthew H. Taylor · University of Saskatchewan1 papers (2019–2019)Wen Lin · Jinan University1 papers (2019–2019)Patrick A. Ott · Harvard University1 papers (2019–2019)Roger Dansey · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2012–2012)— · 1 papers (2014–2014)Qi Jiang · Inner Mongolia University1 papers (2012–2012)Scott Antonia · Parker Institute for Cancer Immunotherapy1 papers (2019–2019)Paolo Vescovi · University of Ferrara1 papers (2014–2014)Emiliano Calvo · Start1 papers (2019–2019)Jean‐Jacques Body · Université Libre de Bruxelles1 papers (2012–2012)— · 1 papers (2012–2012)Christine L. Hann · Johns Hopkins University1 papers (2019–2019)Leora Horn · Vanderbilt University1 papers (2019–2019)— · 1 papers (2019–2019)Norikazu Masuda · Kyoto University1 papers (2012–2012)Karen Chung · Viking Therapeutics (United States)1 papers (2012–2012)Lesley Fallowfield · Brighton and Sussex Medical School1 papers (2012–2012)Neal Ready · Duke University1 papers (2019–2019)D. Ross Camidge · University of Colorado Anschutz Medical Campus1 papers (2019–2019)